Physician profile
James E Lai
NPI 1407992001
$2,158.91
in general payments reported to CMS, 2019-2025
12 companies · $542 in 2025
The $542 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $505 · 2020: $122 · 2021: $98.22 · 2022: $66.86 · 2023: $391 · 2024: $433 · 2025: $542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,366.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,064.67 | 2019-2025 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $521.99 | 2019-2024 | Mitraclip, 2nd Gen Centrimag Primary Console |
| Boston Scientific Corporation | $373.57 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $57.10 | 2024 | Lifevest |
| Philips North America LLC | $42.84 | 2020-2021 | |
| Shockwave Medical, INC | $19.78 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Heartflow, INC. | $15.92 | 2021 | |
| Pfizer INC. | $15.00 | 2025 | |
| Abiomed | $14.08 | 2019 | |
| Medtronic Vascular, INC. | $13.27 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $12.44 | 2021 | |
| Acist Medical Systems, INC. | $8.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.